Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark Deleted their review
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark commented on gene: ACADM
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark Marked gene: ACADM as ready
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark Gene: acadm has been classified as Green List (High Evidence).
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark Classified gene: ACADM as Green List (high evidence)
Genomic newborn screening: ICoNS v0.3 ACADM Zornitza Stark Gene: acadm has been classified as Green List (High Evidence).
Genomic newborn screening: ICoNS v0.1 ACADM Lilian Downie gene: ACADM was added
gene: ACADM was added to Genomic newborn screening: ICoNS. Sources: Expert list
Mode of inheritance for gene: ACADM was set to BIALLELIC, autosomal or pseudoautosomal
Phenotypes for gene: ACADM were set to Acyl-CoA dehydrogenase, medium chain, deficiency of MIM# 201450
Review for gene: ACADM was set to GREEN
Added comment: Well established gene-disease association.

Inherited deficiency of medium-chain acyl-CoA dehydrogenase is characterized by intolerance to prolonged fasting, recurrent episodes of hypoglycemic coma with medium-chain dicarboxylic aciduria, impaired ketogenesis, and low plasma and tissue carnitine levels. Can be severe, potentially fatal.

Typical presentation is between 3 and 24 months.

More than 98% of cases of MCAD deficiency have a pathogenic variant in ACADM, with the c.985A>G variant accounting for between 56-91% of cases.

Treatment: management plan to avoid fasting.

ClinGen: Strong Actionability in paediatric patients.

Non-genetic confirmatory tests: Urine acylglycine analysis

Included in BabyScreen+, BabySeq, BeginNGS, Guardian, Generation, EarlyCheck
Sources: Expert list